Nova Eye Medical Analysis

Nova Pink Sheet Analysis Notes

About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Nova Eye Medical recorded a loss per share of 0.02. The entity last dividend was issued on the 21st of July 2020. Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia. Nova Eye operates under Medical Devices classification in the United States and is traded on OTC Exchange.The quote for Nova Eye Medical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Nova Eye Medical call Gerard Wallace at 61 8 8362 0193 or check out https://nova-eye.com.

Nova Eye Medical Investment Alerts

Nova Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nova Eye's market, we take the total number of its shares issued and multiply it by Nova Eye's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Nova Profitablity

The company has Profit Margin (PM) of (0.56) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.72.

Nova Eye Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Nova Eye prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nova shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Nova Eye. By using and applying Nova Pink Sheet analysis, traders can create a robust methodology for identifying Nova entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

If you are still planning to invest in Nova Eye Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nova Eye's history and understand the potential risks before investing.